KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Asset Utilization Ratio (2018 - 2025)

Historic Asset Utilization Ratio for Amneal Pharmaceuticals (AMRX) over the last 8 years, with Q3 2025 value amounting to 0.84.

  • Amneal Pharmaceuticals' Asset Utilization Ratio rose 868.92% to 0.84 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.84, marking a year-over-year increase of 868.92%. This contributed to the annual value of 0.8 for FY2024, which is 2171.18% up from last year.
  • As of Q3 2025, Amneal Pharmaceuticals' Asset Utilization Ratio stood at 0.84, which was up 868.92% from 0.84 recorded in Q2 2025.
  • In the past 5 years, Amneal Pharmaceuticals' Asset Utilization Ratio ranged from a high of 0.84 in Q2 2025 and a low of 0.5 during Q1 2021
  • Moreover, its 5-year median value for Asset Utilization Ratio was 0.63 (2023), whereas its average is 0.65.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first skyrocketed by 2521.28% in 2021, then soared by 384.38% in 2022.
  • Quarter analysis of 5 years shows Amneal Pharmaceuticals' Asset Utilization Ratio stood at 0.53 in 2021, then increased by 8.98% to 0.58 in 2022, then increased by 15.96% to 0.67 in 2023, then increased by 20.03% to 0.8 in 2024, then rose by 4.15% to 0.84 in 2025.
  • Its Asset Utilization Ratio was 0.84 in Q3 2025, compared to 0.84 in Q2 2025 and 0.82 in Q1 2025.